This inventor holds 3 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Innogenetics N.v., Innogenetics, S.a.. Active years: 2002-2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2002-2012
Title: The Innovative Contributions of Leen-Jan Van Doorn
Introduction
Leen-Jan Van Doorn is a notable inventor based in Ridderkerk, Netherlands, recognized for his significant contributions to the field of virology through his innovations related to the hepatitis C virus (HCV). With a portfolio of three patents, his work aims to advance the understanding and treatment of HCV, a major medical concern worldwide.
Latest Patents
Leen-Jan Van Doorn's latest patents include groundbreaking inventions that focus on previously unrecognized clades of HCV genotypes. His first patent, titled "HCV clade and prototype sequences thereof," pertains to diagnostic, prophylactic, and therapeutic applications of nucleic acids, proteins, and antibodies based on newly characterized hepatitis C viruses. The second patent, titled "Hepatitis C virus genotype, and its use as prophylactic, therapeutic, and diagnostic agent," details genomic nucleotide sequences and amino acid sequences corresponding to a new type of HCV distinct from known types. This innovation provides novel type-specific sequences, which significantly enhance the sensitivity of HCV detection and improve overall diagnosis and treatment strategies.
Career Highlights
Throughout his career, Leen-Jan Van Doorn has made substantial strides in his field while working at organizations like Innogenetics, S.A. and Innogenetics (a Belgian biotechnology company). His research and inventions have been crucial in shaping the current landscape of HCV diagnostics and therapeutics.
Collaborations
Leen-Jan has collaborated with notable professionals in his field, including Wim Quint and Erwin Sablon. These partnerships have contributed to the successful development and dissemination of his innovative ideas, reflecting the importance of teamwork in scientific advancements.
Conclusion
In conclusion, Leen-Jan Van Doorn's work exemplifies the essence of innovation in the medical field, particularly with his focus on hepatitis C. His patents and collaborations underline his commitment to improving health outcomes through scientific research and development. As the landscape of diagnostic and therapeutic applications continues to evolve, Van Doorn's contributions will remain invaluable in the fight against HCV.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile